Michael Vasconcelles has been named the chief medical officer of Cambridge, MA-based cellular immunotherapy startup Unum Therapeutics. Vasconcelles was previously the head of oncology at Takeda Pharmaceuticals. Unum, meanwhile, raised a $65 million Series B round in June to lay the foundation for a future IPO.
From Our Editors · Special Report
Key indicators & expert insight from industry leaders
Xconomy
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
From Our Partners · Special Report
Advice for funding and future transformational opportunities
